See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus

Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths.

Neppl Huber, C; Zappa, M; Coebergh, JW; Rapiti, E; Rachtan, J; Holleczek, B; Rosso, S; Aareleid, T; Brenner, H; Gondos, A and the EUNICE Survival Working Group. (2012). Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths. Annals of Oncology, 23 (5), 1325−1334.
ajakirjaartikkel
Neppl Huber, C; Zappa, M; Coebergh, JW; Rapiti, E; Rachtan, J; Holleczek, B; Rosso, S; Aareleid, T; Brenner, H; Gondos, A and the EUNICE Survival Working Group.
  • Inglise
Annals of Oncology
1569-8041
23
5
2012
13251334
Ilmunud
1.1. Teadusartiklid, mis on kajastatud Web of Science andmebaasides Science Citation Index Expanded, Social Sciences Citation Index, Arts & Humanities Citation Index ja/või andmebaasis Scopus (v.a. kogumikud)
WOS

Viited terviktekstile

Seotud asutused

Lisainfo

prostate cancer, prostate-specific antigen, registries, survival